SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-307078
Filing Date
2017-10-10
Accepted
2017-10-10 16:06:04
Documents
4
Period of Report
2017-10-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d474391d8k.htm 8-K 13161
2 EX-99.1 d474391dex991.htm EX-99.1 13524
3 GRAPHIC g474391g36y70.jpg GRAPHIC 3560
4 GRAPHIC g474391g42s80.jpg GRAPHIC 3479
  Complete submission text file 0001193125-17-307078.txt   37729
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 171130539
SIC: 2834 Pharmaceutical Preparations